|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net (loss)/income | ||
| Adjustments to reconcile net profit to net cash (used in) provided by operating activities: | ||
| Depreciation | ||
| Shared based compensation | ||
| Allowance for credit losses | ||
| Non-cash operating lease expenses | ||
| Deferred tax (benefit) expenses | ||
| Change in operating assets and liabilities: | ||
| Accounts receivable, net | ||
| Prepayments and other assets, net | ||
| Accounts payable | ||
| Income tax payables | ||
| Operating lease liabilities | ||
| Accrued expenses and other liabilities | ||
| Net cash (used in) provided by operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of property and equipment | ||
| Cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from short-term bank loans | ||
| Repayments of short-term bank loans | ||
| Payment of offering costs related to Initial Public Offering (“IPO”) | ||
| Proceeds from IPO | ||
| Repayment of borrowings to a related party | ||
| Net cash provided by (used in) financing activities | ||
| Effect of exchange rate changes on cash and restricted cash | ||
| Net increase in cash and restricted cash | ||
| Cash and restricted cash, beginning of year | ||
| Cash and restricted cash, end of year | ||
| Reconciliation of cash and restricted cash to the consolidated balance sheets | ||
| Cash and cash equivalents | ||
| Total cash and restricted cash | ||
| Supplemental disclosures of cash flow information: | ||
| Income tax paid | ||
| Interest expenses paid | ||
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities |
Loading...
